These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 19212618

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis.
    Bai Z, Ye Y, Chen D, Shen D, Xu F, Cui Z, Wang S.
    APMIS; 2007 Dec; 115(12):1383-90. PubMed ID: 18184409
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M, Ito T, Tanaka E, Shimada Y.
    Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer.
    Tang H, Wang J, Bai F, Zhai H, Gao J, Hong L, Xie H, Zhang F, Lan M, Yao W, Liu J, Wu K, Fan D.
    Cancer Invest; 2008 Feb; 26(1):60-7. PubMed ID: 18181047
    [Abstract] [Full Text] [Related]

  • 8. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.
    Fan Z, Li J, Dong B, Huang X.
    Clin Cancer Res; 2005 Sep 01; 11(17):6162-70. PubMed ID: 16144916
    [Abstract] [Full Text] [Related]

  • 9. CDX2 as a prognostic marker in gastric cancer.
    Masood MA, Loya A, Yusuf MA.
    Acta Gastroenterol Belg; 2016 Sep 01; 79(2):197-200. PubMed ID: 27382937
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Expression of osteopontin mRNA and its clinical significance in gastric cancer].
    Sun XJ, Zuo WS, Ma H, Hou WH, Cai SP, Jiang XH.
    Zhonghua Zhong Liu Za Zhi; 2005 May 01; 27(5):292-5. PubMed ID: 15996323
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
    Cheng HC, Liu YP, Shan YS, Huang CY, Lin FC, Lin LC, Lee L, Tsai CH, Hsiao M, Lu PJ.
    Carcinogenesis; 2013 Nov 01; 34(11):2452-9. PubMed ID: 23774402
    [Abstract] [Full Text] [Related]

  • 18. CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance.
    Park DY, Srivastava A, Kim GH, Mino-Kenudson M, Deshpande V, Zukerberg LR, Song GA, Lauwers GY.
    Mod Pathol; 2010 Jan 01; 23(1):54-61. PubMed ID: 19820687
    [Abstract] [Full Text] [Related]

  • 19. Down regulation of gastric and intestinal phenotypic expression in Epstein-Barr virus-associated stomach cancers.
    Hirano N, Tsukamoto T, Mizoshita T, Koriyama C, Akiba S, Campos F, Carrasquilla G, Carrascal E, Cao X, Toyoda T, Ban H, Miki K, Tatematsu M.
    Histol Histopathol; 2007 Jun 01; 22(6):641-9. PubMed ID: 17357094
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.